VKGILS-NH2 (TFA)-Get quote

Description

VKGILS-NH2 TFA is a reversed amino acid sequence control peptide for SLIGKV-NH2 (protease-activated receptor 2 (PAR2) agonist). VKGILS-NH2 TFA has no effect on DNA synthesis in cells[1][2].—COVID-19-immunoregulation–C30H55F3N8O9—-[1]M Tognetto, et al. Evidence That PAR-1 and PAR-2 Mediate Prostanoid-Dependent Contraction in Isolated Guinea-Pig Gallbladder. Br J Pharmacol. 2000 Oct;131(4):689-94.|[2]David A Vesey, et al. Proinflammatory and Proliferative Responses of Human Proximal Tubule Cells to PAR-2 Activation. Am J Physiol Renal Physiol. 2007 Nov;293(5):F1441-9.–2828432-41-1–728.80—-OC[C@@H](C(N)=O)NC([C@H](CC(C)C)NC([C@H]([C@@H](C)CC)NC(CNC([C@H](CCCCN)NC([C@H](C(C)C)N)=O)=O)=O)=O)=O.O=C(O)C(F)(F)F–Inflammation/Immunology–10 mM in DMSO–Protease Activated Receptor (PAR)–PAR2–GPCR/G Protein–Peptides